We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About MycoWorks Stock

Invest in or calculate the value of your shares in MycoWorks or other pre-IPO companies through EquityZen's platform.

Get Started

MycoWorks Stock (MYCW)

MycoWorks is a biotech company that delivers commercially viable non-plastic and non-animal materials to the market.

About MycoWorks Stock

Founded

2013

Headquarters

Emeryville, CA, US

Industries

Manufacturing, Data and Analytics, Science and Engineering

MycoWorks is engaged in the creation of sustainable design solutions with advanced biomaterials. The company’s proprietary custom-engineered material is sustainable, versatile, and animal-free, and feels and performs like leather. Their first product, Reishi, and the proprietary platform to make it, Fine Mycelium, are a groundbreaking approach to biomaterials that delivers unparalleled versatility and unmatched performance in strength, durability, and hand feel. The perfect intersection of art and science, Reishi is the only natural material that performs like cowhide leather and is engineered to meet the highest quality standards. MycoWorks was founded by Sophia Wang and Philip Ross in 2013 and is based in Emeryville, California.

MycoWorks Management

Leadership team at MycoWorks

CEO

Matthew Scullin

Co-Founder & Chief of Staff and Culture

Sophia Wang

Locked Features

Join now and verify your accreditation status to gain access to:

  • MycoWorks current valuation
  • MycoWorks stock price
  • Available deals in MycoWorks and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in MycoWorks stock?

Accredited investors can buy pre-IPO stock in companies like MycoWorks through EquityZen funds. These investments are made available by existing MycoWorks shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell MycoWorks stock?

Shareholders can sell their MycoWorks stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."